These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 9209512
1. The defined attenuated Listeria monocytogenes delta mp12 mutant is an effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma. Paglia P, Arioli I, Frahm N, Chakraborty T, Colombo MP, Guzmàn CA. Eur J Immunol; 1997 Jun; 27(6):1570-5. PubMed ID: 9209512 [Abstract] [Full Text] [Related]
2. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes. Loeffler DI, Schoen CU, Goebel W, Pilgrim S. Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768 [Abstract] [Full Text] [Related]
3. Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen. Medina E, Paglia P, Rohde M, Colombo MP, Guzmán CA. Eur J Immunol; 2000 Mar; 30(3):768-77. PubMed ID: 10741391 [Abstract] [Full Text] [Related]
4. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. Schafer R, Portnoy DA, Brassell SA, Paterson Y. J Immunol; 1992 Jul 01; 149(1):53-9. PubMed ID: 1607662 [Abstract] [Full Text] [Related]
5. Yersinia enterocolitica Yop mutants as oral live carrier vaccines. Leibiger R, Niedung K, Geginat G, Heesemann J, Trülzsch K. Vaccine; 2008 Dec 02; 26(51):6664-70. PubMed ID: 18822332 [Abstract] [Full Text] [Related]
6. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model. Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X. Int J Mol Med; 2012 Dec 02; 30(6):1335-42. PubMed ID: 23027427 [Abstract] [Full Text] [Related]
7. The tumor recall response of antitumor immunity primed by a live, recombinant Listeria monocytogenes vaccine comprises multiple effector mechanisms. Weiskirch LM, Pan ZK, Paterson Y. Clin Immunol; 2001 Mar 02; 98(3):346-57. PubMed ID: 11237558 [Abstract] [Full Text] [Related]
8. Fine-tuning the safety and immunogenicity of Listeria monocytogenes-based neonatal vaccine platforms. Loeffler DI, Smolen K, Aplin L, Cai B, Kollmann TR. Vaccine; 2009 Feb 05; 27(6):919-27. PubMed ID: 19059297 [Abstract] [Full Text] [Related]
11. Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma. Bast RC, Zbar B, Mackaness GB, Rapp HJ. J Natl Cancer Inst; 1975 Mar 05; 54(3):749-56. PubMed ID: 804566 [Abstract] [Full Text] [Related]
17. Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens. Mata M, Paterson Y. J Immunol; 1999 Aug 01; 163(3):1449-56. PubMed ID: 10415046 [Abstract] [Full Text] [Related]